(DT) Dynatrace Holdings - Overview
Stock: Observability Platform, Monitoring Analytics
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -3.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.62 |
| Alpha | -60.40 |
| Character TTM | |
|---|---|
| Beta | 1.046 |
| Beta Downside | 1.093 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.38% |
| CAGR/Max DD | -0.17 |
Description: DT Dynatrace Holdings January 03, 2026
Dynatrace Holdings (NYSE:DT) delivers an AI-driven observability platform that consolidates infrastructure, application, security, log, and business analytics into a single SaaS offering. The solution helps enterprises streamline cloud operations, accelerate secure software delivery, and monitor digital experience across a global customer base spanning banking, government, retail, and transportation. Revenue is generated through a mix of direct sales and a partner ecosystem that includes global system integrators, cloud providers, and technology alliances, while professional services such as implementation, consulting, and training supplement the core subscription model.
Key recent metrics indicate strong market traction: FY 2023 total revenue reached $1.13 billion, representing a 23 % year-over-year increase, and the company reported a 31 % growth in annual recurring revenue (ARR) driven by higher adoption of AI-augmented monitoring. The broader application-software sector is benefitting from a secular shift toward cloud-native architectures, with worldwide cloud-infrastructure spend projected to exceed $1 trillion in 2025, fueling demand for integrated observability tools. Competitive pressure remains high, with rivals such as New Relic, Splunk, and Elastic expanding their AI capabilities, which underscores the importance of Dynatrace’s proprietary Davis AI engine for differentiation.
For a deeper, data-centric assessment of Dynatrace’s valuation and risk profile, consider exploring ValueRay’s analytical framework, which can help surface hidden assumptions and quantify upside potential.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 506.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -1.44 > 1.0 |
| NWC/Revenue: 36.68% < 20% (prev 27.87%; Δ 8.81% < -1%) |
| CFO/TA 0.12 > 3% & CFO 507.0m > Net Income 506.3m |
| Net Debt (-1.14b) to EBITDA (272.1m): -4.18 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (304.3m) vs 12m ago 0.97% < -2% |
| Gross Margin: 81.50% > 18% (prev 0.81%; Δ 8069 % > 0.5%) |
| Asset Turnover: 49.99% > 50% (prev 46.95%; Δ 3.04% > 0%) |
| Interest Coverage Ratio: -5.78 > 6 (EBITDA TTM 272.1m / Interest Expense TTM -41.5m) |
Altman Z'' 2.12
| A: 0.17 (Total Current Assets 1.84b - Total Current Liabilities 1.16b) / Total Assets 4.08b |
| B: 0.10 (Retained Earnings 390.1m / Total Assets 4.08b) |
| C: 0.06 (EBIT TTM 239.8m / Avg Total Assets 3.71b) |
| D: 0.27 (Book Value of Equity 354.5m / Total Liabilities 1.30b) |
| Altman-Z'' Score: 2.12 = BBB |
Beneish M -3.00
| DSRI: 0.88 (Receivables 315.0m/303.3m, Revenue 1.85b/1.56b) |
| GMI: 1.00 (GM 81.50% / 81.30%) |
| AQI: 0.99 (AQ_t 0.51 / AQ_t-1 0.52) |
| SGI: 1.19 (Revenue 1.85b / 1.56b) |
| TATA: -0.00 (NI 506.3m - CFO 507.0m) / TA 4.08b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = AA |
What is the price of DT shares?
Over the past week, the price has changed by -11.50%, over one month by -21.09%, over three months by -26.81% and over the past year by -43.93%.
Is DT a buy, sell or hold?
- StrongBuy: 19
- Buy: 7
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58 | 72.1% |
| Analysts Target Price | 58 | 72.1% |
| ValueRay Target Price | 31.8 | -5.7% |
DT Fundamental Data Overview February 07, 2026
P/E Forward = 18.6916
P/S = 5.4474
P/B = 3.7553
P/EG = 1.6411
Revenue TTM = 1.85b USD
EBIT TTM = 239.8m USD
EBITDA TTM = 272.1m USD
Long Term Debt = 86.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 17.0m USD (from shortTermDebt, last quarter)
Debt = 86.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.14b USD (from netDebt column, last quarter)
Enterprise Value = 8.95b USD (10.09b + Debt 86.8m - CCE 1.23b)
Interest Coverage Ratio = -5.78 (Ebit TTM 239.8m / Interest Expense TTM -41.5m)
EV/FCF = 18.81x (Enterprise Value 8.95b / FCF TTM 476.1m)
FCF Yield = 5.32% (FCF TTM 476.1m / Enterprise Value 8.95b)
FCF Margin = 25.70% (FCF TTM 476.1m / Revenue TTM 1.85b)
Net Margin = 27.33% (Net Income TTM 506.3m / Revenue TTM 1.85b)
Gross Margin = 81.50% ((Revenue TTM 1.85b - Cost of Revenue TTM 342.6m) / Revenue TTM)
Gross Margin QoQ = 81.82% (prev 82.15%)
Tobins Q-Ratio = 2.19 (Enterprise Value 8.95b / Total Assets 4.08b)
Interest Expense / Debt = 12.70% (Interest Expense 11.0m / Debt 86.8m)
Taxrate = 34.28% (29.9m / 87.1m)
NOPAT = 157.6m (EBIT 239.8m * (1 - 34.28%))
Current Ratio = 1.59 (Total Current Assets 1.84b / Total Current Liabilities 1.16b)
Debt / Equity = 0.03 (Debt 86.8m / totalStockholderEquity, last quarter 2.78b)
Debt / EBITDA = -4.18 (Net Debt -1.14b / EBITDA 272.1m)
Debt / FCF = -2.39 (Net Debt -1.14b / FCF TTM 476.1m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.66% (Net Income 506.3m / Total Assets 4.08b)
RoE = 19.01% (Net Income TTM 506.3m / Total Stockholder Equity 2.66b)
RoCE = 8.72% (EBIT 239.8m / Capital Employed (Equity 2.66b + L.T.Debt 86.8m))
RoIC = 5.92% (NOPAT 157.6m / Invested Capital 2.66b)
WACC = 9.76% (E(10.09b)/V(10.18b) * Re(9.77%) + D(86.8m)/V(10.18b) * Rd(12.70%) * (1-Tc(0.34)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.84%
[DCF Debug] Terminal Value 74.09% ; FCFF base≈460.1m ; Y1≈523.9m ; Y5≈719.3m
Fair Price DCF = 34.11 (EV 9.15b - Net Debt -1.14b = Equity 10.28b / Shares 301.5m; r=9.76% [WACC]; 5y FCF grow 16.20% → 2.90% )
EPS Correlation: 20.35 | EPS CAGR: -39.48% | SUE: -1.13 | # QB: 0
Revenue Correlation: 99.67 | Revenue CAGR: 21.12% | SUE: 3.11 | # QB: 16
EPS next Year (2027-03-31): EPS=1.84 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+12.7% | Growth Revenue=+14.7%